Insider Trading History of Duncan Barbara Gayle


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Duncan Barbara Gayle since year 2005. The trader's CIK number is 1353128. At the time of the last reporting, Duncan Barbara Gayle was the Chief Financial Officer of Jounce Therapeutics, Inc. . (stock ticker symbol JNCE). See this page for all insider trading activities at Jounce Therapeutics, Inc. .

Note that in the past Duncan Barbara Gayle also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Duncan Barbara Gayle since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-03-15 JNCE Jounce Therapeutics, Inc. Option Ex 2,000 4.21 8,420
2018-03-15 JNCE Jounce Therapeutics, Inc. Sale 2,000 28.11 56,220
2018-01-26 JNCE Jounce Therapeutics, Inc. Option Ex 4,000 4.21 16,840
2018-01-26 JNCE Jounce Therapeutics, Inc. Sale 4,000 25.00 100,000
2017-10-17 GNMX Aevi Genomic Medicine, Inc. Buy 59,524 1.26 75,000
2016-10-03 ICPT Intercept Pharmaceuticals, Inc. Sale 147 163.20 23,990
2016-07-05 ICPT Intercept Pharmaceuticals, Inc. Sale 146 145.11 21,185
2016-04-04 ICPT Intercept Pharmaceuticals, Inc. Sale 144 130.76 18,829
2016-01-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2016-01-04 ICPT Intercept Pharmaceuticals, Inc. Sale 468 145.90 68,283
2015-10-02 ICPT Intercept Pharmaceuticals, Inc. Sale 54 159.04 8,588
2015-10-01 ICPT Intercept Pharmaceuticals, Inc. Sale 1,000 163.39 163,390
2015-10-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 2,298 4.33 9,957
2015-07-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2015-07-02 ICPT Intercept Pharmaceuticals, Inc. Sale 53 237.76 12,601
2015-07-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,000 8.67 8,667
2015-07-01 ICPT Intercept Pharmaceuticals, Inc. Sale 1,000 242.10 242,100
2015-04-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2015-04-02 ICPT Intercept Pharmaceuticals, Inc. Sale 39 277.70 10,830
2015-03-27 ICPT Intercept Pharmaceuticals, Inc. Sale 1,000 288.94 288,937
2015-01-05 ICPT Intercept Pharmaceuticals, Inc. Sale 141 176.49 24,884
2015-01-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2015-01-02 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,000 31.90 31,900
2015-01-02 ICPT Intercept Pharmaceuticals, Inc. Sale 1,000 156.40 156,400
2014-10-01 ICPT Intercept Pharmaceuticals, Inc. Sale 1,000 233.90 233,897
2014-10-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 2,299 15.95 36,669
2014-07-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2014-04-14 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,154 21.50 24,811
2014-04-14 ICPT Intercept Pharmaceuticals, Inc. Sale 1,154 279.00 321,966
2014-04-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2014-01-15 ICPT Intercept Pharmaceuticals, Inc. Option Ex 5,625 31.90 179,437
2014-01-15 ICPT Intercept Pharmaceuticals, Inc. Sale 5,625 263.12 1,480,038
2014-01-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2013-10-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2013-07-08 ICPT Intercept Pharmaceuticals, Inc. Sale 25,000 45.39 1,134,850
2013-07-08 ICPT Intercept Pharmaceuticals, Inc. Option Ex 25,000 9.82 245,549
2013-07-01 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,298 .00 0
2013-06-19 ICPT Intercept Pharmaceuticals, Inc. Option Ex 50,575 9.24 467,565
2013-06-19 ICPT Intercept Pharmaceuticals, Inc. Sale 50,575 34.50 1,744,837
2013-05-23 ICPT Intercept Pharmaceuticals, Inc. Sale 110 34.54 3,799
2013-05-24 ICPT Intercept Pharmaceuticals, Inc. Option Ex 1,200 8.67 10,400
2013-05-23 ICPT Intercept Pharmaceuticals, Inc. Option Ex 110 8.67 953
2013-05-28 ICPT Intercept Pharmaceuticals, Inc. Sale 4,915 34.50 169,567
2013-05-28 ICPT Intercept Pharmaceuticals, Inc. Option Ex 4,915 8.67 42,598
2013-05-24 ICPT Intercept Pharmaceuticals, Inc. Sale 1,200 34.50 41,400
2013-05-20 ICPT Intercept Pharmaceuticals, Inc. Option Ex 28,200 15.08 425,340
2013-05-20 ICPT Intercept Pharmaceuticals, Inc. Sale 28,200 34.50 972,900
2013-04-09 ICPT Intercept Pharmaceuticals, Inc. Option Ex 6,490 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duncan Barbara Gayle (Chief Financial Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month